Development of 1,3-acetonedicarboxylate-derived glucoside amphiphiles (ACAs) for membrane protein study-Reference-Cited by-同舟云学术

Development of 1,3-acetonedicarboxylate-derived glucoside amphiphiles (ACAs) for membrane protein study

Published:2022 Issue:19 Volume:13 Page:5750-5759
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Lee Ho Jin¹^ORCID,Ehsan Muhammad¹,Zhang Xiang²,Katsube Satoshi³^ORCID,Munk Chastine F.⁴,Wang Haoqing⁵,Ahmed Waqar¹,Kumar Ashwani¹^ORCID,Byrne Bernadette⁶^ORCID,Loland Claus J.⁴^ORCID,Guan Lan³,Liu Xiangyu²,Chae Pil Seok¹^ORCID

Affiliation:

1. Department of Bionano Engineering, Hanyang University, Ansan 155-88, Korea

2. Beijing Advanced Innovation Center for Structural Biology, School of Medicine, School of Pharmaceutical Sciences, Tsinghua University, 100084 Beijing, China

3. Department of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA

4. Department of Neuroscience, University of Copenhagen, Copenhagen, DK-2200, Denmark

5. Department of Molecular and Cellular Physiology, Stanford University, California 94305, USA

6. Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK

Abstract

Newly developed amphiphiles, designated ACAs, are not only efficient at extracting G protein-coupled receptors from the membranes, but also conferred enhanced stability to the receptors compared to the gold standards (DDM and LMNG).

Funder

National Institutes of Health

National Research Foundation of Korea

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/SC/D2SC00539E

Reference69 articles.

1. How many drug targets are there?

2. Understanding Membrane Protein Drug Targets in Computational Perspective